» Articles » PMID: 38698853

The Causality of Gut Microbiota on Onset and Progression of Sepsis: a Bi-directional Mendelian Randomization Analysis

Overview
Journal Front Immunol
Date 2024 May 3
PMID 38698853
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several observational studies have proposed a potential link between gut microbiota and the onset and progression of sepsis. Nevertheless, the causality of gut microbiota and sepsis remains debatable and warrants more comprehensive exploration.

Methods: We conducted a two-sample Mendelian randomization (MR) analysis to test the causality between gut microbiota and the onset and progression of sepsis. The genome-wide association study (GWAS) summary statistics for 196 bacterial traits were extracted from the MiBioGen consortium, whereas the GWAS summary statistics for sepsis and sepsis-related outcomes came from the UK Biobank. The inverse-variance weighted (IVW) approach was the primary method used to examine the causal association. To complement the IVW method, we utilized four additional MR methods. We performed a series of sensitivity analyses to examine the robustness of the causal estimates.

Results: We assessed the causality of 196 bacterial traits on sepsis and sepsis-related outcomes. Genus [odds ratio (OR) 0.81, 95% confidence interval (CI) (0.69-0.94), = 0.007] and genus (OR 0.85, 95% CI 0.74-0.97, = 0.016) had a protective effect on sepsis, whereas genus (OR 1.10, 95% CI 1.01-1.20, = 0.024) increased the risk of sepsis. When it came to sepsis requiring critical care, genus (OR 0.49, 95% CI 0.31-0.76, = 0.002), genus (OR 0.65, 95% CI 0.43-1.00, = 0.049), and genus (OR 0.51, 95% CI 0.34-0.77, = 0.001) emerged as protective factors. Concerning 28-day mortality of sepsis, genus (OR 0.67, 95% CI 0.48-0.94, = 0.020), genus (OR 0.48, 95% CI 0.27-0.86, = 0.013), genus (OR 0.70, 95% CI 0.52-0.95, = 0.023), and genus (OR 0.82, 95% CI 0.68-0.99, = 0.042) presented a protective effect, whereas genus (OR 1.53, 95% CI 1.00-2.35, = 0.049), genus (OR 1.25, 95% CI 1.04-1.50, = 0.019), and genus (OR 1.43, 95% CI 1.02-2.02, = 0.040) presented a harmful effect. Furthermore, genus (OR 0.42, 95% CI 0.19-0.92, = 0.031), genus (OR 0.34, 95% CI 0.14-0.83, = 0.018), and genus (OR 0.43, 95% CI 0.22-0.83, = 0.012) were associated with a lower 28-day mortality of sepsis requiring critical care.

Conclusion: This MR analysis unveiled a causality between the 21 bacterial traits and sepsis and sepsis-related outcomes. Our findings may help the development of novel microbiota-based therapeutics to decrease the morbidity and mortality of sepsis.

Citing Articles

Causal association between gastroesophageal reflux disease and sepsis, and the mediating role of gut bacterial abundance, a Mendelian randomization study.

Fu Z, Jiang Z, Zhao F, Gou T, Jiang L Medicine (Baltimore). 2025; 104(8):e41631.

PMID: 39993106 PMC: 11857025. DOI: 10.1097/MD.0000000000041631.


Causal effect of gut microbiota on venous thromboembolism: a two-sample mendelian randomization study.

Xi L, Wang H, Du J, Liu A, Wang J, Ni Y Thromb J. 2024; 22(1):106.

PMID: 39614282 PMC: 11605883. DOI: 10.1186/s12959-024-00676-7.


Causal Effects of Sleep Quality on Primary Headache and the Mediation via Gut Microbiota: A Mendelian Randomization Study.

Zhao H, Guan D, Ma Z, Yang M, Dong N, Guo J Brain Behav. 2024; 14(11):e70129.

PMID: 39607077 PMC: 11603430. DOI: 10.1002/brb3.70129.


Genetically Predicted Peripheral Immune Cells Mediate the Effect of Gut Microbiota on Influenza Susceptibility.

Wang S, Ou G, Wu J, Chen Y, Xu L, Xu H Int J Mol Sci. 2024; 25(14).

PMID: 39062949 PMC: 11276963. DOI: 10.3390/ijms25147706.

References
1.
Reinhart K, Daniels R, Kissoon N, Machado F, Schachter R, Finfer S . Recognizing Sepsis as a Global Health Priority - A WHO Resolution. N Engl J Med. 2017; 377(5):414-417. DOI: 10.1056/NEJMp1707170. View

2.
Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

3.
Baggs J, Jernigan J, Halpin A, Epstein L, Hatfield K, McDonald L . Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure. Clin Infect Dis. 2017; 66(7):1004-1012. PMC: 7909479. DOI: 10.1093/cid/cix947. View

4.
Palmieri O, Castellana S, Biscaglia G, Panza A, Latiano A, Fontana R . Microbiome Analysis of Mucosal Ileoanal Pouch in Ulcerative Colitis Patients Revealed Impairment of the Pouches Immunometabolites. Cells. 2021; 10(11). PMC: 8624401. DOI: 10.3390/cells10113243. View

5.
Gurung M, Li Z, You H, Rodrigues R, Jump D, Morgun A . Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020; 51:102590. PMC: 6948163. DOI: 10.1016/j.ebiom.2019.11.051. View